Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy
Authors:
- Teresa SevillaTSTeresa Sevilla
- Teresa JaijoTJTeresa Jaijo
- Dolores NauffalDNDolores Nauffal
- Diego ColladoDCDiego Collado
- María José ChumillasMCMaría José Chumillas
- Juan J. VilchezJVJuan J. Vilchez
- Nuria MuelasNMNuria Muelas
- Luis BatallerLBLuis Bataller
- Rosalía DomenechRDRosalía Domenech
- Carmen EspinósCECarmen Espinós
- Francesc PalauFPFrancesc Palau
- 21 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 131 (11) , 3051-3061
Abstract
Cranial nerve involvement in Charcot-Marie-Tooth disease (CMT) is rare, though there are a number of CMT syndromes in which vocal cord paralysis is a characteristic feature. CMT disease due to mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) has been reported to be associated with vocal cord and diaphragmatic palsy. In order to address the prevalence of these complications in patients with GDAP1 mutations we evaluated vocal cord and respiratory function in nine patients from eight unrelated families with this disorder. Hoarseness of the voice and inability to speak loudly were reported by eight patients and one had associated symptoms of respiratory insufficiency. Patients were investigated by means of peripheral and phrenic nerve conduction studies, flexible laryngoscopy, pulmonary function studies and polysomnography. Nerve conduction velocities and pathological studies were compatible with axonal CMT (CMT2). Flexible laryngoscopy showed left vocal cord palsy in four cases, bilateral cord palsies in four cases and was normal in one case. Restrictive respiratory dysfunction was seen in the eight patients with vocal cord paresis who were all chair-bound. These eight had confirmed phrenic nerve dysfunction on neurophysiology evaluation. The patient with normal vocal cord and pulmonary function had a less severe clinical course.This study shows that CMT patients with GDAP1 mutations develop severe disability due to weakness of limb muscles and that laryngeal and respiratory muscle involvement occurs late in the disease process when significant proximal upper limb weakness has developed. The early and predominant involvement of the left vocal cord innervated by the longer left recurrent laryngeal nerve suggests a length dependent pattern of nerve degeneration. In GDAP1 neuropathy, respiratory function should be thoroughly investigated because life expectancy can be compromised due to respiratory failure.Keywords
This publication has 45 references indexed in Scilit:
- A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth diseaseJournal of Human Genetics, 2008
- Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot‐Marie‐Tooth type 4A diseaseJournal of Cellular and Molecular Medicine, 2007
- Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan familiesBrain, 2006
- Confirmation of a hereditary motor and sensory neuropathy IIC locus at chromosome 12q23‐q24Annals of Neurology, 2005
- Mutant dynactin in motor neuron diseaseNature Genetics, 2003
- CMT4A: Identification of a Hispanic GDAP1 founder mutationAnnals of Neurology, 2003
- Distal spinal muscular atrophy with vocal cord paralysis.Journal of Medical Genetics, 1992
- Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field studyArchives of internal medicine (1960), 1989
- Diaphragm weakness in Charcot-Marie-Tooth disease.Thorax, 1988
- Hereditary distal spinal muscular atrophy with vocal cord paralysis.Journal of Neurology, Neurosurgery & Psychiatry, 1980